Research: Pharmaceuticals
Health Care » Pharmaceuticals
Click here to sign up for a Caris Research Account
Company Name
 |
Last Modified | Research |
|---|---|---|
| (ANX) Adventrx No introduction text is currently available for this report. | 8/17/2010 | 2 |
| (ALKS) Alkermes No introduction text is currently available for this report. | 8/06/2010 | 2 |
| (AMLN) Amylin Pharmaceuticals No introduction text is currently available for this report. | 7/22/2010 | 3 |
| (AUXL) Auxilium No introduction text is currently available for this report. | 8/06/2010 | 12 |
| Biotech Sector Update No introduction text is currently available for this report. | 3/30/2009 | 1 |
| (CEPH) Cephalon No introduction text is currently available for this report. | 7/28/2010 | 2 |
| (CBRX) Columbia Laboratories No introduction text is currently available for this report. | 8/13/2009 | 9 |
| (CRXL) Crucell No introduction text is currently available for this report. | 11/17/2009 | 9 |
| (DEPO) Depomed No introduction text is currently available for this report. | 8/06/2010 | 10 |
| (DRRX) Durect Corporation No introduction text is currently available for this report. | 8/06/2010 | 5 |
| (ELN) Elan Corporation No introduction text is currently available for this report. | 2/11/2009 | 9 |
| (LLY) Eli Lilly No introduction text is currently available for this report. | 12/11/2009 | 16 |
| (EBS) Emergent BioSolutions Inc No introduction text is currently available for this report. | 8/18/2010 | 24 |
| (ENDP) Endo Pharmaceuticals No introduction text is currently available for this report. | 8/03/2010 | 17 |
| (ENZN) Enzon Pharmaceuticals Enzon Pharmaceuticals (ENZN) is a biopharmaceutical company that develops, manufactures, and commercializes high value medicines for patients with cancer and other life-threatening conditions. ENZN... click for more | 8/05/2010 | 17 |
| (EURX) Eurand NV No introduction text is currently available for this report. | 5/21/2010 | 6 |
| (FRX) Forest Laboratories No introduction text is currently available for this report. | 7/21/2010 | 2 |
| Generics No introduction text is currently available for this report. | 4/16/2010 | 3 |
| (IDIX) Idenix IDIX is a biopharmaceutical company that discovers, develops and commercializes treatments for human viral infectious diseases, such as hepatitis B (HBV), hepatitis C (HCV) and the human immunodeficiency... click for more | 10/30/2009 | 13 |
| (KG) King Pharmaceuticals No introduction text is currently available for this report. | 8/10/2010 | 2 |
| (MYL) Mylan, Inc. No introduction text is currently available for this report. | 10/29/2009 | 18 |
| (NVLT) Novelos Therapeutics No introduction text is currently available for this report. | 12/09/2009 | 1 |
| (NOVN) Noven Pharmaceuticals No introduction text is currently available for this report. | 8/28/2009 | 3 |
| (ONXX) Onyx Pharmaceuticals Inc. No introduction text is currently available for this report. | 12/17/2009 | 13 |
| (PRX) Par Pharmaceutical No introduction text is currently available for this report. | 8/05/2010 | 27 |
| (Pharmaceuticals) Pharmaceuticals No introduction text is currently available for this report. | 8/25/2010 | 6 |
| (SLXP) Salix Pharmaceuticals No introduction text is currently available for this report. | 8/10/2010 | 17 |
| (SGP) Schering-Plough No introduction text is currently available for this report. | 4/30/2010 | 21 |
| (SCRX) Sciele Pharma Inc. No introduction text is currently available for this report. | 7/31/2008 | 4 |
| (SHPGY ) Shire No introduction text is currently available for this report. | 8/05/2010 | 15 |
| (SCMP) Sucampo Pharmaceuticals No introduction text is currently available for this report. | 3/17/2010 | 11 |
| (VNDA) Vanda Pharmaceuticals No introduction text is currently available for this report. | 11/27/2009 | 11 |
| (VNDA) Vanda Pharmaceuticals No introduction text is currently available for this report. | 10/14/2009 | 2 |
| (WCRX) Warner Chilcott No introduction text is currently available for this report. | 8/09/2010 | 14 |
| (WL6.DE) Wilex AG No introduction text is currently available for this report. | 3/09/2010 | 2 |
| (WYE) Wyeth No introduction text is currently available for this report. | 8/12/2009 | 15 |
Depending on the investment objectives and financial information specific to your situation, the investments discussed or recommended on this website may or may not be suitable for you. It is your responsibility to consider any investment decision carefully. The information contained on this website should not be construed as advice designed to meet the particular needs of any investor. Past performance is not necessarily indicative of future performance, and does not guarantee future results. The price and/or value of any security noted directly or indirectly on this website may fluctuate adversely to your interests, and/or those of other investors. Caris & Company accepts no liability whatsoever for loss or damage of any sort arising out of use of all or part of any information on this website.